Genenta Science S.p.A.
NASDAQ: GNTA
Healthcare
Biotechnology
Italy
Genenta Science S.p.A.'s latest marketcap:
81.39 M
As of 05/19/2025, Genenta Science S.p.A.'s market capitalization has reached $81.39 M. According to our data, Genenta Science S.p.A. is the 25439th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 81.39 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -9,227,140 |
| Shares Out | 18.29 M |
| EPS (ttm) | -0.50 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | n/a |
Market Cap Chart
Data Updated: 05/19/2025
Genenta Science S.p.A.'s yearly market capitalization.
Genenta Science S.p.A. has seen its market value drop from $198.63 M to $81.39 M since 2021, representing a total decrease of 59.02% and an annual compound decline rate (CAGR) of 23.18%.
| Date | Market Cap | Change (%) |
|---|---|---|
| 05/19/2025 | $81.39 M | -4.25% |
| 12/31/2024 | $79.56 M | -11.77% |
| 12/29/2023 | $90.17 M | -10% |
| 12/30/2022 | $100.19 M | -49.56% |
| 12/31/2021 | $198.63 M |
Company Profile
Frequently Asked Questions
As of 05/19/2025, Genenta Science S.p.A. (including the parent company, if applicable) has an estimated market capitalization of $81.39 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Genenta Science S.p.A. global market capitalization ranking is approximately 25439 as of 05/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
| Country or region | Italy |
| Founded | 2014 |
| IPO Date | 12/15/2021 |
| Employees | 13 |
| CEO | |
| Sector | Healthcare |
| Industry | Biotechnology |
| Address | |
| Website |
